H. Takanaga et al., Polymethoxylated flavones in orange juice are inhibitors of P-glycoproteinbut not cytochrome P450 3A4, J PHARM EXP, 293(1), 2000, pp. 230-236
Citations number
38
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
The presence in orange juice of compounds that specifically inhibit the P-g
lycoprotein (P-gp) drug efflux transporter, but not the cytochrome P450 (CY
P) isozyme CYP3A4, was investigated. The uptake of [H-3]vinblastine, a subs
trate of P-gp, by Caco-2 cells was measured. An ethyl acetate extract of or
ange juice did not affect the initial uptake rate of [H-3]vinblastine but s
ignificantly increased the steady-state uptake, as did cyclosporin A (20 mu
M), an inhibitor of P-gp. No significant effect on the uptake of 9-O-[H-3]
methylglucose or [C-14]phenylalanine by Caco-2 cells was found, compared wi
th the control. When the extract was separated on a Cosmosil column, the el
uate with 70% methanol showed the most potent ability to increase [H-3]vinb
lastine uptake. Additional separation of the 70% methanol eluate on a silic
a gel column with hexane-acetone (3:1) gave 3,3',4',5,6,7,8-heptamethoxyfla
vone (HMF) and 4',5,6,7,8-penta-methoxyflavone (tangeretin). HMF, tangereti
n, and 3',4',5,6,7,8-hexamethoxyflavone (nobiletin), another methoxyflavone
contained in orange juice, all increased the steady-state uptake of [H-3]v
inblastine by Caco-2 cells in a concentration-dependent manner. The order o
f potency of these compounds at the concentration of 50 mu M was tangeretin
> HMF > nobiletin. None of these methoxyflavones inhibited 6 beta-hydroxyl
ation of testosterone catalyzed by CYP3A4. The ethyl acetate extract of ora
nge juice and these methoxyflavones also increased steady-state [H-3]vinbla
stine uptake by LLC-GA5-COL300 cells (a cell line transfected with human MD
R1 cDNA). We conclude that these methoxyflavones enhanced vinblastine uptak
e by specifically inhibiting drug efflux via P-gp. They may have potential
as agents for reversing multidrug resistance or for recovering the bioavail
ability of certain drugs.